These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18368283)

  • 1. Behavioural characterisation of rats exposed neonatally to bisphenol-A: responses to a novel environment and to methylphenidate challenge in a putative model of attention-deficit hyperactivity disorder.
    Kiguchi M; Fujita S; Oki H; Shimizu N; Cools AR; Koshikawa N
    J Neural Transm (Vienna); 2008 Jul; 115(7):1079-85. PubMed ID: 18368283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral responses to methylphenidate and apomorphine in rats exposed neonatally to bisphenol-A.
    Kiguchi M; Fujita S; Lee J; Shimizu N; Koshikawa N
    J Oral Sci; 2007 Dec; 49(4):311-8. PubMed ID: 18195515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The spontaneously hypertensive rat/Izm (SHR/Izm) shows attention deficit/hyperactivity disorder-like behaviors but without impulsive behavior: therapeutic implications of low-dose methylphenidate.
    Kishikawa Y; Kawahara Y; Yamada M; Kaneko F; Kawahara H; Nishi A
    Behav Brain Res; 2014 Nov; 274():235-42. PubMed ID: 25151620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylphenidate administration reverts attentional inflexibility in adolescent rats submitted to a model of neonatal hypoxia-ischemia: Predictive validity for ADHD study.
    Miguel PM; Deniz BF; Confortim HD; Bronauth LP; de Oliveira BC; Alves MB; Silveira PP; Pereira LO
    Exp Neurol; 2019 May; 315():88-99. PubMed ID: 30771298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The spontaneously hypertensive rat as an animal model of attention-deficit hyperactivity disorder: effects of methylphenidate on exploratory behavior.
    Wultz B; Sagvolden T; Moser EI; Moser MB
    Behav Neural Biol; 1990 Jan; 53(1):88-102. PubMed ID: 2302145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylphenidate and venlafaxine attenuate locomotion in spontaneously hypertensive rats, an animal model of attention-deficit/hyperactivity disorder, through α2-adrenoceptor activation.
    Umehara M; Ago Y; Kawanai T; Fujita K; Hiramatsu N; Takuma K; Matsuda T
    Behav Pharmacol; 2013 Aug; 24(4):328-31. PubMed ID: 23751518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prefrontal cortical and striatal transcriptional responses to the reinforcing effect of repeated methylphenidate treatment in the spontaneously hypertensive rat, animal model of attention-deficit/hyperactivity disorder (ADHD).
    dela Peña I; Kim HJ; Sohn A; Kim BN; Han DH; Ryu JH; Shin CY; Noh M; Cheong JH
    Behav Brain Funct; 2014 May; 10():17. PubMed ID: 24884696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioural and pharmacological magnetic resonance imaging assessment of the effects of methylphenidate in a potential new rat model of attention deficit hyperactivity disorder.
    Hewitt KN; Shah YB; Prior MJ; Morris PG; Hollis CP; Fone KC; Marsden CA
    Psychopharmacology (Berl); 2005 Aug; 180(4):716-23. PubMed ID: 15864553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Behavioral and pharmacological studies of juvenile stroke-prone spontaneously hypertensive rats as an animal model of attention-deficit/hyperactivity disorder].
    Ueno K; Togashi H; Yoshioka M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Feb; 23(1):47-55. PubMed ID: 12690641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylphenidate attenuates rats' preference for a novel spatial stimulus introduced into a familiar environment: assessment using a force-plate actometer.
    Fowler SC; Zarcone TJ; Levant B
    J Neurosci Methods; 2010 May; 189(1):36-43. PubMed ID: 20346982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adolescent methylphenidate treatment differentially alters adult impulsivity and hyperactivity in the Spontaneously Hypertensive Rat model of ADHD.
    Somkuwar SS; Kantak KM; Bardo MT; Dwoskin LP
    Pharmacol Biochem Behav; 2016 Feb; 141():66-77. PubMed ID: 26657171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual differences in novelty-seeking behavior in spontaneously hypertensive rats: Enhanced sensitivity to the reinforcing effect of methylphenidate in the high novelty-preferring subpopulation.
    dela Peña I; Gonzales EL; de la Peña JB; Kim BN; Han DH; Shin CY; Cheong JH
    J Neurosci Methods; 2015 Aug; 252():48-54. PubMed ID: 25169048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylphenidate treatment beyond adolescence maintains increased cocaine self-administration in the spontaneously hypertensive rat model of attention deficit/hyperactivity disorder.
    Baskin BM; Dwoskin LP; Kantak KM
    Pharmacol Biochem Behav; 2015 Apr; 131():51-6. PubMed ID: 25643872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioural and pharmacological relevance of stroke-prone spontaneously hypertensive rats as an animal model of a developmental disorder.
    Ueno KI; Togashi H; Mori K; Matsumoto M; Ohashi S; Hoshino A; Fujita T; Saito H; Minami M; Yoshioka M
    Behav Pharmacol; 2002 Feb; 13(1):1-13. PubMed ID: 11990715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of perinatal methylphenidate (MPH) treatment on postweaning behaviors of male and female Sprague-Dawley rats.
    Ferguson SA; Delbert Law C; Sahin L; Montenegro SV
    Neurotoxicol Teratol; 2015; 47():125-36. PubMed ID: 25514582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereoselective effects of methylphenidate on motor hyperactivity in juvenile rats induced by neonatal 6-hydroxydopamine lesioning.
    Davids E; Zhang K; Tarazi FI; Baldessarini RJ
    Psychopharmacology (Berl); 2002 Feb; 160(1):92-8. PubMed ID: 11862378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of neonatal treatment with 6-hydroxydopamine and endocrine disruptors on motor activity and gene expression in rats.
    Masuo Y; Ishido M; Morita M; Oka S
    Neural Plast; 2004; 11(1-2):59-76. PubMed ID: 15303306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of attention-deficit/hyperactivity disorder symptoms by short- and long-acting methylphenidate over the course of a day.
    Günther T; Kahraman-Lanzerath B; Knospe EL; Herpertz-Dahlmann B; Konrad K
    J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):131-8. PubMed ID: 22364402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation rearing as a preclinical model of attention/deficit-hyperactivity disorder.
    Yates JR; Darna M; Gipson CD; Dwoskin LP; Bardo MT
    Behav Brain Res; 2012 Oct; 234(2):292-8. PubMed ID: 22580232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of methylphenidate treatment during adolescence on norepinephrine transporter function in orbitofrontal cortex in a rat model of attention deficit hyperactivity disorder.
    Somkuwar SS; Kantak KM; Dwoskin LP
    J Neurosci Methods; 2015 Aug; 252():55-63. PubMed ID: 25680322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.